Skip to main content

Table 1 Characteristics of study population

From: Assessment of adiposity distribution and its association with diabetes and insulin resistance: a population-based study

 

Non-diabetes

Diabetes

P value

n (%)

7442 (78.4)

2054 (21.6)

< 0.0001

Age (years)

55.1 ± 7.7

58.8 ± 8.6

< 0.0001

Male [n (%)]

2062 (27.7)

630 (30.7)

0.008

Physical activity (MET-h/week)

22.4 (10.5–45.0)

21.0 (10.5–42.0)

0.497

Current smoking [n (%)]

731 (10.0)

204 (10.2)

0.817

Current drinking [n (%)]

238 (3.3)

75 (3.7)

0.311

SBP (mmHg)

124.4 ± 16.1

132.2 ± 16.8

< 0.0001

DBP (mmHg)

74.9 ± 9.8

76.9 ± 9.9

< 0.0001

TG (mmol/L)

1.21 (0.89–1.73)

1.57 (1.08–2.26)

< 0.0001

TC (mmol/L)

5.17 ± 1.22

5.28 ± 1.36

0.0006

HDL-C (mmol/L)

1.34 ± 0.36

1.23 ± 0.35

< 0.0001

LDL-C (mmol/L)

3.13 ± 0.94

3.18 ± 1.03

0.040

FPG (mmol/L)

5.29 (4.93–5.67)

6.46 (5.71–7.69)

< 0.0001

OGTT 2 h glucose (mmol/L)

6.90 (5.87–8.10)

11.67 (9.39–13.55)

< 0.0001

HbA1c (%)

5.80 (5.60–6.10)

6.60 (6.30–7.20)

< 0.0001

Fasting insulin (μIU/mL)

6.80 (5.10–9.40)

8.70 (6.00–12.40)

< 0.0001

HOMA-IR

1.60 (1.16–2.25)

2.61 (1.75–3.85)

< 0.0001

γ-GGT (U/L)

19.0 (14.0–27.0)

24.0 (17.0–36.0)

< 0.0001

eGFR (mL/min per 1.73 m2)

102.3 ± 22.6

99.5 ± 27.1

< 0.0001

BMI

23.4 ± 3.3

24.7 ± 3.5

< 0.0001

WC (cm)

80.7 ± 9.2

85.2 ± 9.9

< 0.0001

WHR

0.86 (0.82–0.90)

0.89 (0.85–0.94)

< 0.0001

WHtR

0.51 (0.47–0.54)

0.54 (0.50–0.58)

< 0.0001

VAI

1.55 (1.03–2.44)

2.20 (1.40–3.50)

< 0.0001

BAI

28.9 (26.3–31.7)

29.7 (26.8–32.9)

< 0.0001

LAP

24.4 (14.4–41.2)

38.9 (22.5–61.9)

< 0.0001

  1. Data were mean ± SD or medians (interquartile ranges) for skewed variables or numbers (proportions) for categorical variables
  2. P values were for the ANOVA or χ2 analyses across the groups
  3. MET-h/wk separate metabolic equivalent hours per week, SBP systolic blood pressure, DBP diastolic blood pressure, TG triglycerides, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, FPG fasting plasma glucose, OGTT oral glucose tolerance test, HOMA-IR homeostasis model assessment of insulin resistance, eGFR estimated glomerular filtration rate, γ-GGT γ-glutamyltransferase, BMI body mass index, WC waist circumference, WHR waist-hip ratio, WHtR waist-height ratio, VAI visceral adiposity index, BAI body adiposity index, LAP lipid accumulation product index
  4. * P < 0.05 compared with non-diabetes group